Page last updated: 2024-11-05

tripelennamine and Leukopenia

tripelennamine has been researched along with Leukopenia in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ZARATZIAN, VL1

Other Studies

1 other study available for tripelennamine and Leukopenia

ArticleYear
The role of histamine in drug-induced eosinopenia and the blocking effects of tripelennamine hydrochloride.
    Toxicology and applied pharmacology, 1959, Volume: 1

    Topics: Eosinophils; Histamine; Leukocyte Count; Leukopenia; Tripelennamine

1959